<DOC>
	<DOCNO>NCT01632540</DOCNO>
	<brief_summary>This study prospective observational study `` real world '' BDP nasal aerosol user PAR , without seasonal allergic rhinitis ( SAR ) . Subjects respond monthly online survey regard rhinitis control , concomitant medical condition , concomitant ( non-AR ) medication , current AR therapy , adverse event .</brief_summary>
	<brief_title>Effectiveness Beclomethasone Dipropionate Nasal Aerosol Perennial Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<criteria>Male female Age 12 year great time enrollment Diagnosis PAR least one year ; 2 ) positive skin prick ( ie , epicutaneous ) serumspecific IgE test within past 2 year perennial allergen appropriate location ; 3 ) PAR symptom consistent exposure allergen least one year Uncontrolled rhinitis symptom time assessment confirm score 21 less RCAT Newly prescribe BDP Nasal Aerosol ( within past 7 day yet use ) Willing able complete survey English computer internet access Willing able provide inform consent prior enter study ( parent/caregiver/legal guardian applicable ) Current acute chronic sinusitis chronic purulent nasal discharge Rhinitis medicamentosa nasal structural abnormality ( include nasal polyp clinically significant septal deviation ) significantly interfere nasal airflow Acute upper respiratory infection within past 14 day Used pressurized metereddose inhaler INS product ( include BDP Nasal Aerosol Ciclesonide Nasal Aerosol ) within past 90 day Used experimental therapy AR within past 30 day Any condition investigator feel may interfere study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>